Equine osteoarthritis, as you know, is the most common cause of lameness in active horses and as such is part of your daily workload. Vetoquinol is pleased to announce a first in Europe in terms of a new and innovative approach to joint health management through nutrition.

is the latest addition to the Flexadin range and the patented ingredient, UC-II^® sets itself apart from other joint management ingredients not only by its nutritional virtue that is based on its privileged and natural interaction with the digestive tract and associated immune tissues resulting in its unique action (known as "Oral tolerisation") but also by its recently published clinical study performed in the horse.

Vetoquinol has also provided for you a comprehensive Equine osteoarthritis management fact sheet to assist your clients in their understanding of this all too common phenomenon..